BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GoodLifeSci - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GoodLifeSci
X-ORIGINAL-URL:https://goodlifesci.sidley.com
X-WR-CALDESC:Events for GoodLifeSci
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20250723T130000
DTEND;TZID=America/Chicago:20250723T163000
DTSTAMP:20260414T085011
CREATED:20250611T160543Z
LAST-MODIFIED:20250625T215158Z
UID:2345-1753275600-1753288200@goodlifesci.sidley.com
SUMMARY:Bay Area Lifesciences Roundtable Navigating Uncertainty and Charting a New Course
DESCRIPTION:Join industry leaders\, investors\, and seasoned regulatory counsel for an exclusive event focused on thriving during times of change in the life sciences sector. Through dynamic panel discussions\, we’ll explore the latest trends in regulation\, financing\, market dynamics\, and federal health policy\, all with a focus on how companies can continue to realize the transformative impact of new therapies and technologies. Don’t miss this opportunity to connect\, learn\, and chart a new course for long-term business success. \nRSVP here. \nAGENDA\nRegistration | 1:00 p.m.\nProgram | 1:30 p.m.\nReception 4:30 p.m. \nWho may be interested in attending: Executives\, Directors\, Investors\, and In-House Counsel \nFEATURED PANELS \nRegulatory Realities – Proactive Strategies in a Shifting Landscape \nExplore how companies are developing new strategies to respond to the latest developments at HHS\, FDA\, and CMS\, including major shifts in FDA leadership\, staffing\, and policy priorities\, potential impacts on regulatory timelines and new product approvals\, and new proposals related to drug pricing and reimbursement. Hear from industry insiders on how to engage effectively with regulators and adapt to new expectations in an era of uncertainty. \nSPEAKERS\n \n\nAnthony Davies\, Ph.D.\, Founder & CEO\, Dark Horse Consulting\nHae-Won Min Liao\, Vice President\, U.S. Legal Business Partner\, Gilead Sciences\nEmily Marden\, Senior Counsel\, Sidley\nCatherine Starks\, Partner\, Sidley\n\nAdditional panelists to be announced \nFinancing the Future – Paths to Growth and Liquidity \nDiscover how investment opportunities are evolving\, with a focus on financing and liquidity options including debt\, royalty financing\, mergers\, and other strategic transactions. Leading advisors and investors will share their experience\, including how shifting geopolitical and regulatory factors are shaping deals\, and what it takes to secure funding and achieve liquidity in today’s market. \nSPEAKERS\n \n\nRyuk Byun\, Managing Director\, Morgan Stanley\nHutch Corbett\, Managing Partner\, Armentum Partners\nCarlton Fleming\, Partner\, Sidley\nFrank Rahmani\, Partner\, Sidley\n\nAdditional panelists to be announced \nThe GLP-1 Effect – Disruption\, Demand\, and What’s Next for Biotech \n Using GLP-1 as a case study\, dive into the latest trends in product development\, pricing and reimbursement\, market dynamics\, and federal health policy. This panel will examine issues that have arisen for the paradigm-shifting GLP-1/GIP/Gcg product category\, to reveal for the future of innovation across the entire life sciences industry. \nSPEAKERS \n\nScott Akamine\, Chief Legal Officer\, Kailera Therapeutics\nMichael Hulka\, Senior Vice President and Deputy General Counsel\, Eli Lilly and Company\nTorrey Cope\, Partner\, Sidley\n\nAdditional panelists to be announced \nCLE credit for this program is pending.\n\nFor more information\, contact sfevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/bay-area-lifesciences-roundtable-navigating-uncertainty-and-charting-a-new-course/
LOCATION:SFMOMA\, 147 Minna St. Floor 5\, San Francisco\, CA\, 94103\, United States
END:VEVENT
END:VCALENDAR